What is Body Vision?
Body Vision Medical operates at the intersection of artificial intelligence and interventional pulmonology. Its flagship LungVision system represents a paradigm shift in diagnostic imaging, effectively transforming standard X-ray inputs into high-fidelity, real-time CT-like scans. By providing clinicians with enhanced visualization during biopsies and localized therapeutic procedures, the company addresses the urgent need for higher diagnostic yields in lung cancer detection. The platform is engineered to support pulmonologists and thoracic surgeons, offering a scalable solution that improves clinical confidence and patient outcomes through superior precision and accessibility in complex medical interventions.
How much funding has Body Vision raised?
Body Vision has raised a total of $28.5M across 2 funding rounds:
Series A
$8.5M
Series C
$20M
Series A (2018): $8.5M, investors not publicly disclosed
Series C (2019): $20M, investors not publicly disclosed
Key Investors in Body Vision
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Body Vision?
With this major enterprise-level funding, Body Vision is well-positioned to scale its commercial operations and deepen its research and development pipeline. The strategic focus will likely shift toward expanding the clinical footprint of the LungVision platform across global healthcare systems, while simultaneously refining its AI algorithms to support broader diagnostic applications. As the company transitions from a scaling phase to a market-leader trajectory, the focus remains on integrating its technology into standard clinical workflows, thereby reducing the time-to-diagnosis and improving the efficacy of early-stage lung cancer interventions. Future growth will be defined by the company's ability to maintain its technological edge while navigating the complex regulatory and reimbursement landscapes inherent in the medical device industry.
See full Body Vision company page
